NAMA
BMY icon

Nikko Asset Management Americas’s Bristol-Myers Squibb BMY Stock Holding History

Nikko Asset Management Americas’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-194,780
Closed -$12.9M – 209
2021
Q2 		$12.9M Sell
194,780
-73,723
-27% -$4.81M 0.05% 117
2021
Q1 		$17M Buy
268,503
+32,292
+14% +$2.01M 0.08% 112
2020
Q4 		$14.7M Buy
236,211
+20,985
+10% +$1.29M 0.08% 114
2020
Q3 		$12.9M Sell
215,226
-18,378
-8% -$1.11M 0.11% 99
2020
Q2 		$13.7M Sell
233,604
-179,430
-43% -$10.7M 0.18% 75
2020
Q1 		$23M Sell
413,034
-154,370
-27% -$9.44M 0.43% 60
2019
Q4 		$36.4M Sell
567,404
-317,653
-36% -$18.2M 0.57% 50
2019
Q3 		$44.9M Buy
885,057
+80,818
+10% +$3.8M 0.8% 40
2019
Q2 		$36.5M Buy
804,239
+551,258
+218% +$25.7M 0.72% 40
2019
Q1 		$12.1M Buy
+252,981
New +$12.6M 0.32% 60
2018
Q3 		– Sell
-58,200
Closed -$3.22M – 158
2018
Q2 		$3.22M Buy
+58,200
New +$3.14M 0.1% 135
2017
Q3 		– Sell
-9,600
Closed -$535K – 342
2017
Q2 		$535K Hold
9,600
– – 0.03% 177
2017
Q1 		$522K Hold
9,600
– – 0.04% 167
2016
Q4 		$561K Buy
9,600
+200
+2% +$10.9K 0.05% 152
2016
Q3 		$507K Hold
9,400
– – 0.04% 150
2016
Q2 		$686K Hold
9,400
– – 0.07% 124
2016
Q1 		$596K Hold
9,400
– – 0.07% 124
2015
Q4 		$653K Hold
9,400
– – 0.07% 120
2015
Q3 		$554K Hold
9,400
– – 0.06% 120
2015
Q2 		$620K Hold
9,400
– – 0.04% 130
2015
Q1 		$618K Hold
9,400
– – 0.05% 134
2014
Q4 		$558K Sell
9,400
-13,700
-59% -$773K 0.04% 142
2014
Q3 		$1.19M Buy
23,100
+8,100
+54% +$405K 0.07% 101
2014
Q2 		$736K Sell
15,000
-4,200
-22% -$207K 0.04% 122
2014
Q1 		$995K Buy
19,200
+1,300
+7% +$69.2K 0.05% 105
2013
Q4 		$957K Buy
17,900
+12,000
+203% +$611K 0.04% 111
2013
Q3 		$273K Buy
+5,900
New +$259K 0.01% 132

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nikko Asset Management Americas's BMY Position: Q3 2021 in Review

Nikko Asset Management Americas sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 194,780 shares — an estimated $12.9M sold.

Nikko Asset Management Americas first reported a position in BMY in Q3 2013 and held it in 27 quarters. The position peaked at $44.9M in Q3 2019. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Nikko Asset Management Americas reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
  • Nikko Asset Management Americas sold 194,780 Bristol-Myers Squibb shares in Q3 2021, an estimated $12.9M.
  • Nikko Asset Management Americas first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 27 quarters.
  • Nikko Asset Management Americas's Bristol-Myers Squibb position peaked at $44.9M in Q3 2019.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Nikko Asset Management Americas's 13F filing for Q3 2021, filed 9 Nov 2021.